The legacy success of copyright’s flagship drug has undeniably transformed the drug landscape. However, putting money in companies heavily reliant on copycat drugs and the waning patent exclusivity https://brightbookmarks.com/story21607202/the-blue-pill-and-pharmaceutical-companies-a-speculative-investment